A recent federal government report on Medicare Advantage (MA) plans reveals a concerning issue: billions of dollars are being funneled into MA companies through inflated, risk-adjusted payments based on questionable diagnoses. This situation not only drains taxpayer dollars but also raises potential issues in patient care and program integrity. If you're aware of specific misconduct […]
The Securities and Exchange Commission (SEC) has outlined its examination priorities for fiscal year 2025, aiming to bolster investor protection and market integrity. These priorities serve as a crucial resource for potential whistleblowers who may witness violations within the financial sector, particularly as the SEC intensifies its focus on areas that pose risks to investors. […]
On October 10, the Department of Justice, Financial Crimes Enforcement Network (FinCEN), Federal Reserve, and Office of the Comptroller of Currency imposed over $3 billion in penalties on TD Bank. TD Bank pled guilty to violating the Bank Secrecy Act and conspiring to commit money laundering. The case is history-marking for two reasons. First, the […]
Liz Soltan recently wrote for Bloomberg Law News, analyzing the SEC’s settlement with Keurig Dr. Pepper. The settlement alleges Keurig made inaccurate statements about the recyclability of its K-cup pods. Keurig paid a $1.5 million civil penalty. Liz’s article was also included in the Daily Update email from Securities Docket. Keurig stated in its public […]
Last week brought bombshell news for all those who care about stopping fraud on the government. And it wasn’t the good kind. On September 30, Judge Kathryn Kimball Mizelle, a federal judge in Tampa, Florida, held that the qui tam provisions of the False Claims Act are unconstitutional. Those provisions allow whistleblowers to sue on […]
Several news outlets have highlighted our client’s historic $79 million whistleblower award, shared with two other whistleblowers. The award is one of the largest ever made under the IRS Whistleblower Program for exposing tax fraud, with the whistleblowers helping the government recover more than $263 million. The press coverage has focused not only on the […]
Whistleblower Partners represents whistleblowers who contributed to the government’s recovery of $27 million from Precision Toxicology under the False Claims Act for allegedly overcharging Medicaid and Medicare for urine drug testing. As the addiction crisis unfortunately continues to spread, urine drug testing is a regular component of addiction centers and other recovery options. The government […]
In September 2024, Oak Street Health (OSH), a primary care provider group with hundreds of locations in several states, agreed to pay $60 million to settle a whistleblower case brought under the False Claims Act (FCA). The FCA allows private individuals to sue in the name of the United States to allege fraud against the […]
ONE OF THE LARGEST AWARDS EVER UNDER THE IRS WHISTLEBLOWER PROGRAM
Whistleblower Partners is proud to announce that the IRS Whistleblower Program has awarded our client, along with two other whistleblowers, a maximum 30% reward in the total amount of $79 million for helping expose and shut down a longstanding and complex tax fraud. It is one of the largest awards in program history. Our client […]
